AR and Alzheimer disease: For certain IEIs, including HIES, STAT1-GOF, APDS, ALPS, IPEX, AR-CGD, and autosomal dominant (AD)-CD46 deficiency, FCM offered suggestive evidence, necessitating subsequent genetic testing for confirmation.